Related Experiment Video
Updated: Mar 5, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
974
Screening utilization among cancer survivors: a meta-analysis
Annemarie Uhlig1,2, Janet Mei2, Inhye Baik2
1Department of Urology, University Medical Center Goettingen, 37075 Goettingen, Germany.
Journal of Public Health (Oxford, England)
|March 24, 2017
Summary
Cancer survivors demonstrate higher utilization of cancer screening services compared to cancer-free individuals. This meta-analysis confirms increased screening for breast, colorectal, and cervical cancers in survivors.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- Conflicting evidence exists regarding cancer screening service utilization in cancer survivors versus cancer-free populations.
- This study addresses the disparity by synthesizing available research through a meta-analysis.
Purpose of the Study:
- To quantitatively assess and compare cancer screening service utilization between adult cancer survivors and cancer-free controls.
- To synthesize evidence on screening for breast, colorectal, and cervical cancers in cancer survivors.
Main Methods:
- A systematic literature review was performed in August 2016.
- Included studies compared screening service utilization for breast, colorectal, and cervical cancers in adult cancer survivors against cancer-free controls.
- Random effects meta-analyses were employed to aggregate study estimates.
Main Results:
- Nineteen studies, selected from 3538 initial records, met the inclusion criteria.
- Cancer survivors showed significantly higher utilization rates for breast cancer screening (OR = 1.27, 95% CI: 1.13-1.42).
- Increased utilization was also observed for colorectal cancer (OR = 1.25, 95% CI: 1.15-1.37) and cervical cancer screening (OR = 1.38, 95% CI: 1.08-1.75) among survivors.
Conclusions:
- Cancer survivors are more likely to utilize cancer screening services than their cancer-free counterparts.
- Further research is warranted to determine if this increased screening uptake translates to improved long-term survival outcomes.
Related Concept Videos
01:21Cancer Survival Analysis
806
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
806
01:20Comparing the Survival Analysis of Two or More Groups
677
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
677
02:59Cancer Prevention
8.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.5K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:24Kaplan-Meier Approach
674
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
674